Sentinel node biopsy in breast cancer;Die Biopsie des leitenden Lymphknotens beim Mammakarzinom

Acta Chirurgica Austriaca

Volumn 32, Issue 3, 2000, Pages 105-109

  Schrenk, P ^a,d   Haid, A ^b   Tausch, C ^c   Gebhard, Barbara ^e   Reitsamer, R ^e  

^a H Chirurgischen Abt des A K L   (Austria)

^b Chirurgischen Abt des L F   (Austria)

^c C A des A O K der B S   (Austria)

^d KEPLER UNIVERSITY HOSPITAL   (Austria)

^e Sonderstation f�r Frauenheilkunde und Geburtshilfe der Landeskrankenanstalten Salzburg ^*  (Austria)

Author keywords

Axillary lymph node dissection; Axillary staging; Breast cancer; Sentinel node biopsy

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; QUALITY CONTROL;

EID: 0033916158     PISSN: 0001544X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02948149     Document Type: Article

References (39)

1. (1) Alazraki NP, Eshima D, Eshima LA, Herda SC, Murray DR, Vansant JP, Taylor AT: Lymphoscintigraphy, the Sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Sem in Nuc Med 1997; 27: 55-67.
2. (2) Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. J Am Med Assoc 1996; 276: 1818-1822.
3. (3) Anderson BO, Austin-Seymour MM, Gralow JR, Moe RE, Byrd DR: A multidisciplinary approach to locoregional management of the axilla for primary operable breast cancer. Cancer Control 1998; 4: 491-499.
4. (4) Boova RS, Bonanni R, Rosato FE: Patterns of axillary nodal involvement in breast cancer: predictability of level one dissection. Ann Surg 1982; 196: 642-644.
5. (5) Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S: Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-283.
6. (6) Cady B: Is axillary lymph node dissection necessary in routine management of breast cancer? No. Breast J 1997; 5: 246-260.
7. (7) Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer 1989; 63: 181-187.
8. (8) De Cicco C, Chinol M, Paganelli G: Intraoperative localization of the sentinel node in breast cancer: technical aspects of lymphoscintigraphic methods. Semin Surg Oncol 1998; 15: 268-271.
9. (9) Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS: Guidelines for Sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645-653.
10. (10) Dowlatshahi K, Fan M, Snider HC, Habib FA: Lymph node micrometastases from breast carcinoma. Cancer 1997; 80: 1188-1197.
11. (11) Feigelson BJ, Acosta JA, Feigelson HS, Findley A, Saunders EL: T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection. Am J Surg 1996; 172: 487-489.
12. (12) Fein DA, Fowble BL, Hanlon AL, Hooks MA, Hoffman JP, Sigurdson ER, Jardines LA, Eisenberg BL: Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol 1997; 65: 34-39.
13. (13) Frykberg ER, Bland KI: Management of in situ and minimally invasive breast carcinoma. World J Surg 1994; 18: 45-57.
14. (14) Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-401.
15. (15) Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345-2350.
16. (16) Haid A, Fritze H, Peschina W, Gruber-Mösenbacher U, Jasarevic S, Hillbrand E, Müller G, Köberle-Würer R, Schmidle T, Breitenfellner G: Die Sentinel Node Biopsie beim Mammakarzinom - Ein minimal invasives Verfahren zum exakten Staging der Axilla. Wien Med Wschr 1999; 111: 219-225.
17. (17) Hainsworth PJ, Tjandra JJ, Stillwell RG, Machet D, Henderson MA, Rennie GC, McKenzie IFC, Bennett RC: Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993; 80: 459-463.
18. (18) International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990; 335: 1565-1568.
19. (19) Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The Sentinel node in breast Cancer: a multicenter validation study. N Engl J Med 1998; 339: 941-946.
20. (20) Lacour J, Le MG, Caceres E, Koszarowski T, Veronisi U, Hill C: Radical mastectomy versus radical mastectomy plus internal mammary dissection: 10-years results of an international cooperative trial breast cancer. Cancer 1983; 51: 1941-1943.
21. (21) Mascarel I, Bonichon F, Coindre JM, Trjani M: Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 1992; 66: 523-527.
22. (22) McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett JC, Wright RG: Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996; 73: 88-95.
23. (23) Meyer JS: Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol 1998; 69: 212-218.
24. (24) Morrow M: Axillary dissection: an obsolete operation? Breast J 1998; 4: 330-335.
25. (25) NIH Consensus Conference (1991) Treatment of early stage breast cancer. J Am Med Assoc 265: 391-396.
26. (26) Noel P, Chauvin F, Michot JP, Catimel G, Hesch M, Groleas M: Prognostic value of lymph node micrometastases detected by immunhistochemistry. Study of 168 cases of breast cancer with a ten year follow-up. Ann Pathol 1991; 11: 309-315.
27. (27) O'Hea BJ, Hill ADK, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, Borgen PI, Cody HS: Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-427.
28. (28) Pigott J, Nichols R, Maddox WA, Balch CM: Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet 1984; 158: 255-259.
29. (29) Rosen PP, Lesser ML, Kinne DW, Beattie EJ: Discontinuous or "skip metastases" in breast carcinoma: analysis of 1228 axillary dissections. Ann Surg 1983; 197: 276-283.
30. (30) Schildberg FW, Löhe F: Grundlagen und Wert der Lymphadenektomie beim Mammacarcinom. Chirurg 1996; 67: 771-778.
31. (31) Schneebaum S, Stadler J, Cohen M, Yaniv D, Baron J, Skornick Y: Gamma probe-guided sentinel node biopsy-optimal timing for injection. Eur J Surg Oncol 1998; 24: 515-519.
32. (32) Schrenk P, Hatzl M, Rieger R, Shamiyeh A, Wayand W, Maschek W: Klinische Anwendung der Biopsie des leitenden Lymphknotens beim Mammacarcinom. Chirurg 1998; 69: 1072-1076.
33. (33) Sharma S, Hill ADK, McDermott EW, O'Higgins NJ: Ductal carcinoma of the breast - current management. Eur J Surg Oncol 1997; 23: 191-196.
34. (34) Silverstein MJ: Predicting axillary nodal positivity in 1787 patients with invasive breast carcinoma. Breast J 1998; 4: 324-329.
35. (35) Trojani M, de Mascaral I, Candre JM, Bonichon F: Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987; 55: 303-306.
36. (36) Turner RR, Ollila DW, Krasne DL, Giuliano AE: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226: 271-278.
37. (37) Veronesi U, Cascinelli N, Greco M, Bufalino R, Morabito A, Galluzzo D, Conti R, De Lellis R, Delle Donne V, Piotti P, Sacchini V, Clemente C, Salvadori B: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985; 202: 702-707.
38. (38) Veronesi U, Luini A, Galimberti V, Marchini S, et al: Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990; 16: 127-133.
39. (39) Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867.